Why is the stock of ADMA Biologics Inc. (ADMA) skyrocketing in premarket?
ADMA Biologics, Inc. (ADMA) a biopharmaceutical company focused on commercializing specialty plasma-derived biologics, confirmed that the U.S. Food and Drug Administration (FDA) has approved the Company’s enlarged production process, which allows fractionation and purification of plasma pool with a 4400 liter volume, to produce Intravenous Immune Globulin (“IVIG”). ADMA stock surged adjacent to the news. […]
Why is the stock of ADMA Biologics Inc. (ADMA) skyrocketing in premarket? Read More »